Spotify Looking to Fine-Tune Music Rights

Jason Tate

Hannah Karp, writing at The Wall Street Journal:

Spotify is now operating on short-term extensions of its old contracts with all three major record companies, having been on a month-to-month basis with at least one of the labels for nearly a year. It is negotiating new deals that would make its finances more attractive to investors.

Spotify, which saw its net loss increase to roughly $200 million last year even as revenue doubled to more than $2 billion, wants to pay a smaller share than the nearly 55% of its revenue that it currently pays to record labels and artists, according to people familiar with the matter.

It pays roughly an additional 15% to music publishers and songwriters.

But some major label executives want Spotify to pay them as much as 58% of revenue from both its free and paid tiers. That is what Apple Inc. pays for Apple Music subscribers who aren’t on free trials, people familiar with the matter said. Apple has more than 5 million users on free trials, they said.

Interview: Bayside

Bayside
Craig Ismaili

Bayside have steadily become one of the preeminent forces in alternative music by simply being themselves throughout their entire career. The band has a unique sense of self which displays itself every time they release new music. The band’s seventh full-length record, Vacancy, just dropped last week, and to celebrate, they hit the road with some incredible bands supporting them: The Menzingers and Sorority Noise. I’ll have more on that tour a little later this week, but for now, enjoy my conversation with Anthony Raneri and Nick Ghanbarian about managing fan expectations, what they feel their responsibility is as a band with a platform, and how you continue to write the most honest music of your career seven albums deep.

Read More “Bayside”

Review: Sianvar – Stay Lost

Sianvar - Stay Lost
Zac Djamoos

Knowing the members of Sianvar, the quality of their work should never have been up for debate. Featuring members of Dance Gavin Dance, A Lot Like Birds, Hail the Sun, and Stolas, the lineup is a veritable who’s-who of modern progressive rock. It was never a secret that Sianvar was made up of talented members, but I don’t know if anyone expected the group’s debut full-length to sound as good as it does. Stay Lost almost makes the members’ previous outings look like warm ups.

Read More “Sianvar – Stay Lost”

Mylan’s EpiPen Price Gouging

Science
Jason Tate

Matt Novak, writing for Gizmodo:

EpiPen, the life-saving allergy product, is now a $1 billion a year business for Mylan, a drug company that’s currently enduring a wave of bad publicity over the extraordinary surge in EpiPen pricing. In 2007, an EpiPen cost about $57. Today that price has skyrocketed to over $600 — all for about $1 worth of injectable medicine.

EpiPen is an emergency medication that’s stabbed into a person experiencing anaphylactic shock, a life-threatening allergic reaction that can be triggered by anything from bee stings to food. I’ve never used an EpiPen, but as someone with a peanut allergy who once made his own trip to the ER after a particularly unfortunate restaurant experience (“these Chinese beans sure are crunchy…”) I can tell you that anaphylactic shock is really no fun.

This is such bullshit.